Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (sJIA): TENDER 52-week data

Spremljeno u:
Bibliografski detalji
Glavni autori: De Benedetti, Fabrizio, Brunner, Hermine, Ruperto, Nicola, Cuttica, R, Malattia, Clara, Schneider, Rayfel, Woo, Patricia, Eleftheriou, Despina, Baildam, Eileen, Burgos-Vargas, Ruben, Dolezalova, Pavla, Garay, Stella M, Joos, Rik, Wulffraat, Nico, Zuber, Zbyszek, Zulian, Francesco, Wouters, Carine, Xavier, Ricardo M, Zemel, Lawrence, Wright, Stephen, Kenwright, Andy, Martini, Alberto, Lovell, Daniel
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2012
Teme:
Oral Presentation
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3402963/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1546-0096-10-S1-A58
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items